secwatch.observer — SEC 8-K summary
======================================

Issuer:     SI-BONE, Inc. (SIBN)
CIK:        0001459839
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001459839-25-000094
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SI-BONE Q3 revenue $48.7M (+20.6% YoY), raises FY2025 guidance
--------------------------------------------------------------

- Net loss improved to $4.6M ($0.11/share) from $6.6M ($0.16) a year ago.
- U.S. revenue $46.4M (+21.2% YoY); gross margin 79.8% (+75 bps); operating cash flow positive $2.3M.
- FY2025 revenue guidance raised to $198M-$200M (from $195M-$198M), implying ~18-20% growth.
- Adjusted EBITDA positive $2.3M vs loss $0.2M; cash and equivalents $145.7M.
- Director Daniel Wolf resigned; Thomas West appointed to Audit Committee; Wolf to consult 12 months, 8,675 RSUs accelerated.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1459839/000145983925000094/0001459839-25-000094-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1459839/000145983925000094/sibn-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001459839-25-000094

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer